Literature DB >> 14680737

Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and "narrow" QRS.

Augusto Achilli1, Massimo Sassara, Sabina Ficili, Daniele Pontillo, Paola Achilli, Claudio Alessi, Stefano De Spirito, Roberto Guerra, Nicolino Patruno, Francesco Serra.   

Abstract

OBJECTIVES: The aim of the study was to evaluate the effectiveness of cardiac resynchronization therapy (CRT) in patients with refractory heart failure (HF) and incomplete left bundle branch block ("narrow" QRS), together with echocardiographic evidence of interventricular and intraventricular asynchrony.
BACKGROUND: Cardiac resynchronization therapy has been proven effective in patients with HF and wide QRS by ameliorating contraction asynchrony.
METHODS: Fifty-two patients with severe HF received biventricular pacing. The patients were eligible in the presence of echocardiographic evidence of interventricular and intraventricular asynchrony, regardless of QRS duration. The patient population was divided into group 1 (n = 38), with a QRS duration >120 ms, and group 2 (n = 14), with a QRS duration < or =120 ms.
RESULTS: The baseline parameters considered in the study were similar in both groups. At follow-up, CRT determined narrowing of the QRS interval in the entire population and in group 1 (p < 0.001), whereas a small increase in QRS duration was observed in group 2 (p = NS); in all patients and within groups, we observed improvement of New York Heart Association functional class (p < 0.001 in all), left ventricular ejection fraction (p < 0.001 in all), left ventricular end-diastolic and end-systolic diameter (p < 0.05 within groups), mitral regurgitation area (p < 0.001 in all), interventricular delay (p < 0.001 in all), and deceleration time (group 1: p < 0.001, group 2: p < 0.05), with no significant difference between groups. The 6-min walking test improved in both groups (group 1: p < 0.001; group 2: p < 0.01).
CONCLUSIONS: Cardiac resynchronization therapy determined clinical and functional benefit that was similar in patients with wide or "narrow" QRS. Cardiac resynchronization therapy may be helpful in patients with echocardiographic evidence of interventricular and intraventricular asynchrony and incomplete left bundle branch block.

Entities:  

Mesh:

Year:  2003        PMID: 14680737     DOI: 10.1016/j.jacc.2003.08.024

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  68 in total

1.  Acute and chronic response to CRT in narrow QRS patients.

Authors:  Tim Donahue; Imran Niazi; Angel Leon; Michael Stucky; Keith Herrmann
Journal:  J Cardiovasc Transl Res       Date:  2011-12-30       Impact factor: 4.132

2.  Utility of three-dimensional echocardiography in assessing and predicting response to cardiac resynchronization therapy.

Authors:  Ching Lau; Husam Mohamed Abdel-Qadir; Ilan Lashevsky; Mark Hansen; Eugene Crystal; Campbell Joyner
Journal:  Can J Cardiol       Date:  2010-11       Impact factor: 5.223

3.  Single photon emission computed tomography (SPECT) techniques for resynchronization: phase analysis and equilibrium radionuclide angiocardiography.

Authors:  Kenneth C Bilchick
Journal:  J Nucl Cardiol       Date:  2011-02       Impact factor: 5.952

Review 4.  Echocardiographic evaluation of cardiac dyssynchrony for predicting a favourable response to cardiac resynchronisation therapy.

Authors:  C M Yu; J J Bax; M Monaghan; P Nihoyannopoulos
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

5.  Cardiac resynchronization therapy: the MGH experience.

Authors:  Jagmeet P Singh; Jeremy N Ruskin
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-10       Impact factor: 1.468

6.  Left ventricular mechanical dyssynchrony assessment in long-standing type II diabetes mellitus patients with normal gated SPECT-MPI.

Authors:  Dharmender Malik; Bhagwant Mittal; Ashwani Sood; Madan Parmar; Gurvinder Kaur; Ajay Bahl
Journal:  J Nucl Cardiol       Date:  2018-02-01       Impact factor: 5.952

7.  Beyond the measurement of QRS complex toward mechanical dyssynchrony: cardiac resynchronisation therapy in heart failure patients with a normal QRS duration.

Authors:  A Auricchio; C M Yu
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

Review 8.  Devices in the management of advanced, chronic heart failure.

Authors:  William T Abraham; Sakima A Smith
Journal:  Nat Rev Cardiol       Date:  2012-12-11       Impact factor: 32.419

9.  Association of corrected QT dispersion with symptoms improvement in patients receiving cardiac resynchronization therapy.

Authors:  Kazuyoshi Hina; Hiroshi Kawamura; Takashi Murakami; Keizo Yamamoto; Hirosuke Yamaji; Masaaki Murakami; Satoshi Hirohata; Hiroko Ogawa; Kohsuke Sakane; Shozo Kusachi
Journal:  Heart Vessels       Date:  2008-09-20       Impact factor: 2.037

Review 10.  Implantable defibrillators with and without resynchronization for patients with left ventricular dysfunction.

Authors:  Sanjiv M Narayan
Journal:  Tex Heart Inst J       Date:  2005
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.